The Flexible Dosing Syringe (FDS) is suitable for applications involving a single injection of 50 microliters through 5 milliliters.
Can be used in applications requiring modulation of injection volume based on patient weight (for example, pediatric vs. adult dosing) or other biomarkers.
Can also be used for biosimilars in oncology and oncology-related treatments.
The FDS can streamline clinical trial design for dose escalation studies. Significant cost savings can be achieved by avoiding reformulation of different strengths of the same drug.
The FDS can be used for applications involving self-injection or caregiver-mediated administration.